• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于设计选择性抑制剂的磷酸二酯酶4(PDE4)特异性口袋的鉴定。

Identification of a PDE4-Specific Pocket for the Design of Selective Inhibitors.

作者信息

Feng Xiaoqing, Wang Huanchen, Ye Mengchun, Xu Xue-Tao, Xu Ying, Yang Wenzhe, Zhang Han-Ting, Song Guoqiang, Ke Hengming

机构信息

School of Pharmaceutical Engineering and Life Sciences , Changzhou University , Changzhou , Jiangsu 213164 , P. R. China.

Department of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center , The University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599-7260 , United States.

出版信息

Biochemistry. 2018 Jul 31;57(30):4518-4525. doi: 10.1021/acs.biochem.8b00336. Epub 2018 Jul 17.

DOI:10.1021/acs.biochem.8b00336
PMID:29975048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6088244/
Abstract

Inhibitors of phosphodiesterases (PDEs) have been widely studied as therapeutics for the treatment of human diseases, but improvement of inhibitor selectivity is still desirable for the enhancement of inhibitor potency. Here, we report identification of a water-containing subpocket as a PDE4-specific pocket for inhibitor binding. We designed against the pocket and synthesized two enantiomers of PDE4 inhibitor Zl-n-91. The ( S)-Zl-n-91 enantiomer showed IC values of 12 and 20 nM for the catalytic domains of PDE4D2 and PDE4B2B, respectively, selectivity several thousand-fold greater than those of other PDE families, and potent neuroprotection activities. Crystal structures of the PDE4D2 catalytic domain in complex with each Zl-n-91 enantiomer revealed that ( S)-Zl-n-91 but not ( R)-Zl-n-91 formed a hydrogen bond with the bound water in the pocket, thus explaining its higher affinity. The structural superposition between the PDE families revealed that this water-containing subpocket is unique to PDE4 and thus valuable for the design of PDE4 selective inhibitors.

摘要

磷酸二酯酶(PDEs)抑制剂作为治疗人类疾病的药物已得到广泛研究,但为提高抑制剂效力,仍需要提高抑制剂的选择性。在此,我们报告鉴定出一个含水亚口袋作为PDE4特异性的抑制剂结合口袋。我们针对该口袋进行设计并合成了PDE4抑制剂Zl-n-91的两种对映体。(S)-Zl-n-91对映体对PDE4D2和PDE4B2B催化结构域的IC值分别为12和20 nM,选择性比其他PDE家族高数千倍,并且具有强大的神经保护活性。PDE4D2催化结构域与每种Zl-n-91对映体复合物的晶体结构表明,(S)-Zl-n-91而非(R)-Zl-n-91与口袋中的结合水形成了氢键,从而解释了其更高的亲和力。PDE家族之间的结构叠加表明,这个含水亚口袋是PDE4特有的,因此对于设计PDE4选择性抑制剂具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/e592c0a93d43/nihms-1502545-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/98f930267516/nihms-1502545-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/681c07c774ca/nihms-1502545-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/0130a274380c/nihms-1502545-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/03227492e5a8/nihms-1502545-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/f85bbe28dbc5/nihms-1502545-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/e592c0a93d43/nihms-1502545-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/98f930267516/nihms-1502545-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/681c07c774ca/nihms-1502545-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/0130a274380c/nihms-1502545-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/03227492e5a8/nihms-1502545-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/f85bbe28dbc5/nihms-1502545-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a60/6088244/e592c0a93d43/nihms-1502545-f0006.jpg

相似文献

1
Identification of a PDE4-Specific Pocket for the Design of Selective Inhibitors.用于设计选择性抑制剂的磷酸二酯酶4(PDE4)特异性口袋的鉴定。
Biochemistry. 2018 Jul 31;57(30):4518-4525. doi: 10.1021/acs.biochem.8b00336. Epub 2018 Jul 17.
2
Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.新型 PDE4 抑制剂 ZL-n-91 对脂多糖诱导的急性肺损伤的作用。
Int Immunopharmacol. 2010 Apr;10(4):406-11. doi: 10.1016/j.intimp.2010.01.003. Epub 2010 Jan 13.
3
Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds.探索水分子在磷酸二酯酶4B(PDE4B)和磷酸二酯酶4D(PDE4D)配体结合结构域中的作用:基于虚拟筛选的一些活性支架分子对接
Curr Comput Aided Drug Des. 2019;15(4):334-366. doi: 10.2174/1573409914666181105153543.
4
Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity.磷酸二酯酶4D(PDE4D)与咯利普兰复合物的三维结构及其对抑制剂选择性的影响
Structure. 2003 Jul;11(7):865-73. doi: 10.1016/s0969-2126(03)00123-0.
5
Thiophene inhibitors of PDE4: crystal structures show a second binding mode at the catalytic domain of PDE4D2.噻吩型 PDE4 抑制剂:晶体结构显示 PDE4D2 催化结构域存在第二种结合模式。
Bioorg Med Chem Lett. 2011 Dec 1;21(23):7089-93. doi: 10.1016/j.bmcl.2011.09.109. Epub 2011 Oct 5.
6
Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure-activity relationships.儿茶酚酰胺作为潜在的选择性磷酸二酯酶4D抑制剂:设计、合成、药理学评价及构效关系
Bioorg Med Chem. 2015 Nov 15;23(22):7332-9. doi: 10.1016/j.bmc.2015.10.033. Epub 2015 Oct 24.
7
Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes.人类和线虫 PDE4 抑制剂结合差异的药理学和分子动力学分析:对寄生虫线虫管理的影响。
PLoS One. 2019 Mar 27;14(3):e0214554. doi: 10.1371/journal.pone.0214554. eCollection 2019.
8
Diastereoselective synthesis and profiling of bicyclic imidazolidinone derivatives bearing a difluoromethylated catechol unit as potent phosphodiesterase 4 inhibitors.具有二氟甲基化儿茶酚单元的双环咪唑烷酮衍生物的非对映选择性合成和分析作为有效的磷酸二酯酶 4 抑制剂。
Org Biomol Chem. 2018 Oct 3;16(38):6900-6908. doi: 10.1039/c8ob01039k.
9
Discovery of 2-(3,4-dialkoxyphenyl)-2-(substituted pyridazin-3-yl)acetonitriles as phosphodiesterase 4 inhibitors with anti-neuroinflammation potential based on three-dimensional quantitative structure-activity relationship study.基于三维定量构效关系研究发现具有抗神经炎症潜力的 2-(3,4-二烷氧基苯基)-2-(取代哒嗪-3-基)乙腈类磷酸二酯酶 4 抑制剂。
Chem Biol Drug Des. 2019 Apr;93(4):484-502. doi: 10.1111/cbdd.13438. Epub 2018 Dec 26.
10
Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors.苯基取代呋喃和噁唑羧酸衍生物的合成及生物活性作为潜在的 PDE4 抑制剂。
Eur J Med Chem. 2020 Dec 1;207:112795. doi: 10.1016/j.ejmech.2020.112795. Epub 2020 Sep 4.

引用本文的文献

1
Advances in pyrazolo[1,5-]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment.吡唑并[1,5 - ]嘧啶的研究进展:合成及其在癌症治疗中作为蛋白激酶抑制剂的作用
RSC Adv. 2025 Feb 5;15(5):3756-3828. doi: 10.1039/d4ra07556k. eCollection 2025 Jan 29.
2
Development of White Cabbage, Coffee, and Red Onion Extracts as Natural Phosphodiesterase-4B (PDE4B) Inhibitors for Cognitive Dysfunction: and Studies.开发白菜、咖啡和红洋葱提取物作为治疗认知功能障碍的天然磷酸二酯酶-4B(PDE4B)抑制剂: 及 研究。
Adv Pharmacol Pharm Sci. 2024 May 21;2024:1230239. doi: 10.1155/2024/1230239. eCollection 2024.
3

本文引用的文献

1
Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.磷酸二酯酶-4B作为认知障碍和肥胖相关代谢疾病的治疗靶点
Adv Neurobiol. 2017;17:103-131. doi: 10.1007/978-3-319-58811-7_5.
2
Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.用于阿尔茨海默病的 I 期和 II 期临床试验的研究性磷酸二酯酶抑制剂。
Expert Opin Investig Drugs. 2017 Sep;26(9):1033-1048. doi: 10.1080/13543784.2017.1364360. Epub 2017 Aug 9.
3
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook.
The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches.
特定 cAMP 磷酸二酯酶家族的复杂性和多样性:PDE4,开辟新的适应治疗方法。
Int J Mol Sci. 2022 Sep 13;23(18):10616. doi: 10.3390/ijms231810616.
4
ZL-n-91, a specific Phosphodiesterase-4 inhibitor, suppresses the growth of triple-negative breast cancer.ZL-n-91是一种特异性磷酸二酯酶-4抑制剂,可抑制三阴性乳腺癌的生长。
Invest New Drugs. 2022 Oct;40(5):875-883. doi: 10.1007/s10637-022-01258-y. Epub 2022 Jun 8.
5
Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor.基于对接的筛选和分子动力学模拟以鉴定潜在的选择性磷酸二酯酶4B抑制剂。
Heliyon. 2020 Sep 14;6(9):e04856. doi: 10.1016/j.heliyon.2020.e04856. eCollection 2020 Sep.
6
DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.DRM02,一种具有皮肤抗炎活性的新型磷酸二酯酶-4 抑制剂。
Tissue Barriers. 2020 Jul 2;8(3):1765633. doi: 10.1080/21688370.2020.1765633. Epub 2020 Jun 1.
7
Identification of a Selective PDE4B Inhibitor From by Target Fishing Study and Evaluation of Quercetin 3--Arabinopyranosyl-(1→2)-Rhamnopyranoside.通过靶点垂钓研究鉴定一种选择性磷酸二酯酶4B(PDE4B)抑制剂并评估槲皮素3 - 阿拉伯吡喃糖基 -(1→2)- 鼠李吡喃糖苷
Front Pharmacol. 2020 Jan 22;10:1582. doi: 10.3389/fphar.2019.01582. eCollection 2019.
磷酸二酯酶 4 抑制剂治疗特应性皮炎:进展与展望。
Drugs. 2017 Sep;77(13):1389-1397. doi: 10.1007/s40265-017-0784-3.
4
Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences.慢性呼吸道疾病中磷酸二酯酶4A、B、C和D亚型的选择性抑制:现状与未来证据
Curr Pharm Des. 2017;23(14):2073-2083. doi: 10.2174/1381612823666170214105651.
5
[33] AMoRe: An automated molecular replacement program package.[33] AMoRe:一个自动分子置换程序包。
Methods Enzymol. 1997;276:581-594. doi: 10.1016/S0076-6879(97)76079-8.
6
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
7
Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.纳米域调控磷酸二酯酶介导的心脏环核苷酸信号。
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:455-479. doi: 10.1146/annurev-pharmtox-010716-104756. Epub 2016 Oct 12.
8
PDE4B as a microglia target to reduce neuroinflammation.磷酸二酯酶4B作为小胶质细胞靶点以减轻神经炎症。
Glia. 2016 Oct;64(10):1698-709. doi: 10.1002/glia.22986. Epub 2016 Apr 1.
9
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.发现用于治疗与神经退行性疾病和神经精神疾病相关的认知障碍的强效且选择性的磷酸二酯酶1抑制剂。
J Med Chem. 2016 Feb 11;59(3):1149-64. doi: 10.1021/acs.jmedchem.5b01751. Epub 2016 Feb 2.
10
Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor.磷酸二酯酶-9A的结构不对称性及一种强效对映体抑制剂选择性结合的独特口袋
Mol Pharmacol. 2015 Nov;88(5):836-45. doi: 10.1124/mol.115.099747. Epub 2015 Aug 27.